128 related articles for article (PubMed ID: 7271829)
1. Studies on the arachidonic acid cascade--I. Inhibition of phospholipase A2 in vitro and in vivo by several novel series of inhibitor compounds.
Wallach DP; Brown VJ
Biochem Pharmacol; 1981 Jun; 30(11):1315-24. PubMed ID: 7271829
[No Abstract] [Full Text] [Related]
2. Serine esterase inhibitor reduces contractions with isolated trachea and lung strips from guinea pigs induced by phospholipase A2.
Slapke J
Allergol Immunopathol (Madr); 1984; 12(4):289-92. PubMed ID: 6334434
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phospholipase A2 activity of guinea-pig alveolar macrophages by lipocortin-like proteins purified from mice lung.
Errasfa M; Bachelet M; Russo-Marie F
Biochem Biophys Res Commun; 1988 Jun; 153(3):1267-70. PubMed ID: 2968795
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet phospholipase-A2 as a mechanism for the anti-aggregating effect of linoleic acid.
Vallee E; Gougat J; Ageron M
Agents Actions; 1980 Apr; 10(1 Pt 2):57-62. PubMed ID: 7386309
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of phospholipase A2 in vitro by some anti-hypoxic drugs.
Nikolov R; Koburova K
Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):429-31. PubMed ID: 6436598
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors.
Vallee E; Gougat J; Navarro J; Delahayes JF
J Pharm Pharmacol; 1979 Sep; 31(9):588-92. PubMed ID: 41058
[TBL] [Abstract][Full Text] [Related]
7. Studies on the incorporation of [1-14C]arachidonic acid into glycerolipids and its conversion into prostaglandins by rabbit iris. Effects of anti-inflammatory drugs and phospholipase A2 inhibitors.
Abdel-Latif AA; Smith JP
Biochim Biophys Acta; 1982 Jun; 711(3):478-89. PubMed ID: 6809058
[TBL] [Abstract][Full Text] [Related]
8. Role of phospholipase and calmodulin inhibitors on insulin, arachidonic acid and prostaglandin E2 release.
Gagliardino JJ; Borelli MI; de Gagliardino EE; García ME
Diabetes Res Clin Pract; 1985-1986 Mar; 1(6):327-33. PubMed ID: 3939119
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase A2 products induce pulmonary beta-adrenoceptor deviations.
Raaijmakers JA; Harmsen HJ; De Boer E; Beneker C; Van Rozen RJ
Eur J Pharmacol; 1986 Aug; 127(1-2):163-4. PubMed ID: 3019725
[No Abstract] [Full Text] [Related]
10. Enhancement of insulin release due to inhibition of phospholipase A2 activity.
Tanaka N; Kagawa S; Murakoso K; Shimizu S; Matsuoka A
Horm Metab Res; 1983 May; 15(5):255-6. PubMed ID: 6409772
[No Abstract] [Full Text] [Related]
11. Human recombinant phospholipase A2 inhibits platelet aggregation in vitro and in vivo in rat and guinea pig.
Cirino G; Cicala C; Sorrentino R; Sorrentino L; Browning JL; Page CP
Eur J Pharmacol; 1994 Feb; 252(2):147-54. PubMed ID: 8157055
[TBL] [Abstract][Full Text] [Related]
12. Modification of the arachidonic acid cascade through phospholipase A2 dependent mechanisms.
Dennis EA
Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():217-23. PubMed ID: 2144695
[No Abstract] [Full Text] [Related]
13. Effect of p-bromophenacyl bromide, an inhibitor of phospholipase A2, on prostaglandin production by the guinea-pig uterus [proceedings].
Mitchell SM; Poyser NL; Wilson NH
Br J Pharmacol; 1976 Oct; 58(2):295P. PubMed ID: 974411
[No Abstract] [Full Text] [Related]
14. [Simultaneous and sequential inhibition of the arachidonic acid cascade by inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases in carrageenan edema and adjuvant arthritis in the rat].
Bekemeier H; Hirschelmann R; Ramanampison ML; Pantović D
Pharmazie; 1986 Jun; 41(6):406-8. PubMed ID: 3094043
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of human platelet phospholipase A2 by buffering cytoplasmic calcium with the fluorescent indicator quin 2. Evidence for different calcium sensitivities of phospholipases A2 and C.
Simon MF; Chap H; Douste-Blazy L
Biochim Biophys Acta; 1986 Feb; 875(2):157-64. PubMed ID: 3080024
[TBL] [Abstract][Full Text] [Related]
16. Prevention of catecholamine release from adrenal chromaffin cells by phospholipase A2- and lipoxygenase-inhibitors.
Sasakawa N; Yamamoto S; Kumakura K; Kato R
Jpn J Pharmacol; 1983 Oct; 33(5):1077-80. PubMed ID: 6417385
[No Abstract] [Full Text] [Related]
17. Inhibition of human phospholipases A2 by cis-unsaturated fatty acids and oligomers of prostaglandin B1.
Franson R; Raghupathi R; Fry M; Saal J; Vishwanath B; Ghosh SS; Rosenthal MD
Adv Exp Med Biol; 1990; 279():219-30. PubMed ID: 2129000
[TBL] [Abstract][Full Text] [Related]
18. Are phospholipid-binding proteins in vivo phospholipase inhibitors?
Poensgen J
Klin Wochenschr; 1989 Feb; 67(3):163-5. PubMed ID: 2494377
[TBL] [Abstract][Full Text] [Related]
19. [Prostaglandins and related substances: regulation of arachidonic acid metabolism by drugs].
Katori M
Nihon Rinsho; 1985 Mar; 43(3):472-9. PubMed ID: 3925195
[No Abstract] [Full Text] [Related]
20. Phospholipase A2 inhibitory activity in thymocytes of dexamethasone-treated mice--possible implication of lipocortins.
Errasfa M; Rothhut B; Russo-Marie F
Biochem Biophys Res Commun; 1989 Feb; 159(1):53-60. PubMed ID: 2522304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
